Olena Mitchenko
Overview
Explore the profile of Olena Mitchenko including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
511
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Elshorbagy A, Vallejo-Vaz A, Barkas F, Lyons A, Stevens C, Dharmayat K, et al.
Eur Heart J
. 2025 Jan;
PMID: 39801189
Background And Aims: Overweight and obesity are modifiable risk factors for atherosclerotic cardiovascular disease (ASCVD) in the general population, but their prevalence in individuals with heterozygous familial hypercholesterolaemia (HeFH) and...
2.
Banach M, Reiner Z, Surma S, Bajraktari G, Bielecka-Dabrowa A, Bunc M, et al.
Drugs
. 2024 Nov;
84(12):1541-1577.
PMID: 39497020
Atherosclerotic cardiovascular disease (ASCVD) and consequent acute coronary syndromes (ACS) are substantial contributors to morbidity and mortality across Europe. Fortunately, as much as two thirds of this disease's burden is...
3.
Ceska R, Latkovskis G, Ezhov M, Freiberger T, Lalic K, Mitchenko O, et al.
Curr Atheroscler Rep
. 2019 Jun;
21(9):36.
PMID: 31230174
Purpose Of Review: Familial hypercholesterolemia (FH) is often perceived and described as underdiagnosed and undertreated, though effective treatment of FH is available. Owing to the mentioned facts, it is ever...
4.
Fogacci F, Banach M, Mikhailidis D, Bruckert E, Toth P, Watts G, et al.
Pharmacol Res
. 2019 Mar;
143:1-16.
PMID: 30844537
Recently, concerns regarding the safety of red yeast rice (RYR) have been raised after the publication of some case reports claiming toxicity. Since the previous meta-analyses on the effects of...
5.
Vallejo-Vaz A, De Marco M, Stevens C, Akram A, Freiberger T, Hovingh G, et al.
Atherosclerosis
. 2018 Oct;
277:234-255.
PMID: 30270054
Background And Aims: Management of familial hypercholesterolaemia (FH) may vary across different settings due to factors related to population characteristics, practice, resources and/or policies. We conducted a survey among the...
6.
Banach M, Patti A, Giglio R, Cicero A, Atanasov A, Bajraktari G, et al.
J Am Coll Cardiol
. 2018 Jun;
72(1):96-118.
PMID: 29957236
Statins are the most common drugs administered for patients with cardiovascular disease. However, due to statin-associated muscle symptoms, adherence to statin therapy is challenging in clinical practice. Certain nutraceuticals, such...
7.
Danchin N, Almahmeed W, Al-Rasadi K, Azuri J, Berrah A, Cuneo C, et al.
Eur J Prev Cardiol
. 2018 May;
25(10):1087-1094.
PMID: 29771156
Background Little is known about the achievement of low density lipoprotein cholesterol (LDL-C) targets in patients at cardiovascular risk receiving stable lipid-lowering therapy (LLT) in countries outside Western Europe. Methods...
8.
Cicero A, Colletti A, Bajraktari G, Descamps O, Djuric D, Ezhov M, et al.
Nutr Rev
. 2017 Sep;
75(9):731-767.
PMID: 28938795
In recent years, there has been growing interest in the possible use of nutraceuticals to improve and optimize dyslipidemia control and therapy. Based on the data from available studies, nutraceuticals...
9.
Cicero A, Colletti A, Bajraktari G, Descamps O, Djuric D, Ezhov M, et al.
Arch Med Sci
. 2017 Sep;
13(5):965-1005.
PMID: 28883839
No abstract available.
10.
Ceska R, Paragh G, Reiner Z, Banach M, Tokgozoglu L, Susekov A, et al.
Vnitr Lek
. 2017 Feb;
63(1):43-48.
PMID: 28225290
Familial hypercholesterolemia (FH) is a genetic disorder with well-known genetic transmission and clinical course. Despite great recent progress, FH is still underestimated, under-diagnosed and thus undertreated. Furthermore it represents a...